El Fondo Español Columbus Life Science y el inglés Advent Life Science han liderado una ronda de inversión de 22,6 millones de euros en la empresa biotecnológica Highlight Therapeutics, que ha con...
Koa Health, a digital mental healthcare provider offering personalized solutions backed by science, today announced it closed an oversubscribed €30 million ($36 million) Series A funding round. The ...
Kurma Partners joined the round which includes and was initially led by Asabys Partners, along with new investors, VI Partners Swiss Innovation and CDTI Innvierte Economía, and existing investors And...
El compromiso adquirido con las gestoras es que los 10 millones de euros logren multiplicar por cinco la inversión hasta alcanzar los 50 millones de euros. El dinero se desembolsará a medida que los...
GENESIS Biomed, a consulting company specialized in R + D projects in biomedicine, has recently established its Business Advisory Board, a multidisciplinary panel of experts, KOL in their respective s...
Aura Biosciences, a clinical-stage oncology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the closing of an oversubsc...
HoMu Health Ventures, la incubadora y Venture Builder para startups del sector biotech, focalizada en salud reproductiva, ha cerrado su primer año de actividad con nueve proyectos en su incubadora. L...
Gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by LAVA, are expected to be $100.5 million. The offering is expected to clos...
The company announces a €14.35M Series A, one of the biggest rounds in the Spanish medtech industry, co-led by Asabys Partners and Alta Life Sciences, joined by CDTI Innvierte and two international ...
mediQuo ha cerrado una nueva ronda de financiación de 2,3 millones de euros que utilizará para expandir comercialmente la plataforma líder de TeleMedicina que conecta profesionales de la salud y su...
Lanzadera, la aceleradora de empresas impulsada por Juan Roig, ha desarrollado el Hub de Innovación en Salud, una iniciativa que agrupará en Marina de Empresa a grandes corporaciones, empresas tecno...
Vivet’s second gene therapy product, VTX-803 for PFIC3, received US and European Orphan Drug Designation in May 2020.Vivet is supported by international life science investors including Novartis Ven...